Judo Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $75M

  • Investors
  • 7

Judo Bio General Information

Description

Developer of oligonucleotide therapies intended to offer genetic medicines. The company helps to pair the gene-silencing nucleic acid with a targeting molecule to specific types of kidney cells, enabling healthcare professionals to treat systemic and renal diseases.

Contact Information

Website
www.judo.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 Technology Square
  • 8th Floor
  • Cambridge, MA 02139
  • United States
+1 (857)
Primary Industry
Drug Discovery
Corporate Office
  • 300 Technology Square
  • 8th Floor
  • Cambridge, MA 02139
  • United States
+1 (857)

Judo Bio Timeline

202220232024
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Judo Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 07-Oct-2024 $75M Completed Pre-Clinical Trials
2. Mezzanine 02-Jun-2024 Completed Stealth
1. Seed Round 21-Nov-2023 $25M $25M Completed Stealth
To view Judo Bio’s complete valuation and funding history, request access »

Judo Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Judo Bio’s complete cap table history, request access »

Judo Bio Patents

Judo Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023239156-A1 Targeted delivery Pending 25-Mar-2022

Judo Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Judo Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Atlas Venture Venture Capital Minority
Digitalis Ventures Venture Capital Minority
Droia Ventures Venture Capital Minority
Euclidean Capital Family Office Minority
You’re viewing 5 of 7 investors. Get the full list »

Judo Bio FAQs

  • When was Judo Bio founded?

    Judo Bio was founded in 2021.

  • Where is Judo Bio headquartered?

    Judo Bio is headquartered in Cambridge, MA.

  • What is the size of Judo Bio?

    Judo Bio has 5 total employees.

  • What industry is Judo Bio in?

    Judo Bio’s primary industry is Drug Discovery.

  • Is Judo Bio a private or public company?

    Judo Bio is a Private company.

  • What is the current valuation of Judo Bio?

    The current valuation of Judo Bio is .

  • What is Judo Bio’s current revenue?

    The current revenue for Judo Bio is .

  • How much funding has Judo Bio raised over time?

    Judo Bio has raised $105M.

  • Who are Judo Bio’s investors?

    Alexandria Venture Investments, Atlas Venture, Digitalis Ventures, Droia Ventures, and Euclidean Capital are 5 of 7 investors who have invested in Judo Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »